The effects of pregnancy on relapse rates, disability and peripartum outcomes in women with multiple sclerosis: a systematic review and meta-analysis
Publication: Journal of Comparative Effectiveness Research
Abstract
Background: Although previous cohort studies of women with multiple sclerosis (MS) yielded a reduction in relapse rate during pregnancy, the effect size has not been quantified in a comprehensive manner. In addition, the effects on disability progression and peripartum outcomes have been controversial. The purpose of this work is to assess the effect of pregnancy on disease activity, and to assess the effects of MS on pregnancy as well. Materials & methods: We searched in PubMed, Cochrane Library and EMBASE for cohort studies dealing with the effects of pregnancy on relapse rates, disability progression and peripartum outcomes in women with MS. The evaluated outcomes were: changes in the annualized relapse rate (ARR) in pregnancy and puerperium, disability worsening compared with the year before pregnancy, and peripartum outcomes, which were compared with the ones of non-MS women. In the majority of cohorts included here, the women were not under disease modifying therapies during pregnancy. Results: We found 23 cohort studies measuring changes in the ARR during pregnancy and puerperium; 12 were prospective and 11 retrospective. In 17 cohorts there was significant reduction in the ARR during pregnancy compared with prepregnancy period. The pooled mean reduction in the ARR was -0.5 (95% CI: 0.67–0.38), p < 0.001, from 15 cohorts included in meta-analysis. In 18 cohorts the ARR increased in the 3-month puerperium relative to prepregnancy year period; the pooled mean increase in the ARR was 0.22 (95% CI: 0.11–0.33), p < 0.001, from 14 cohorts included in meta-analysis. Disability worsening was addressed in 18 cohorts, and in 14 of them there were no significant changes. Peripartum complications and obstetrical outcomes were assessed in 16 cohorts, of whom 13 were retrospective, without finding significant differences. Conclusion: Pregnancy is associated with lower disease activity, and puerperium with higher disease activity. Disability does not change significantly after pregnancy. The obstetrical outcomes are not very different from those of non-MS women in most cohorts.
Formats available
You can view the full content in the following formats:
References
1.
Vidal-Jordana A, Montalban X. Multiple sclerosis: epidemiologic, clinical and therapeutic aspects. Neuroimaging Clin. N. Am. 27(2), 195–204 (2017).
2.
Galetta KM, Bhattacharyya S. Multiple sclerosis and autoimmune neurology of the central nervous system. Med. Clin. North Am. 103(2), 325–336 (2019).
3.
Katz Sand I. Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr. Opin. Neurol. 28, 193–205 (2015).
4.
Schapira K, Poskanzer D, Neill D, Miller H. Marriage, pregnancy and multiple sclerosis. Brain 89, 419–428 (1966).
5.
Liebowitz U, Antonovsky A, Kats R, Alter M. Does pregnancy increase the risk of multiple sclerosis? J. Neurol. Neurosurg. Psych. 30, 354–357 (1967).
6.
Antonovsky A, Liebowitz U, Medalie JM, Smith HA, Halpern L, Alter M. Reappraisal of possible etiologic factors in multiple sclerosis. Am. J. Public Health Nations Health 58, 836–848 (1968).
7.
Avila M, Bansal A, Culberson J, Peiris AN. The role of sex hormones in multiple sclerosis. Eur. Neurol. 80, 93–95 (2018).
8.
Tavakolpour S, Rahimzadeh G. New insights into the management of patients with autoimmune diseases or inflammatory disorders during pregnancy. Scand. J. Immunol. 84(3), 146–149 (2016).
9.
Runmaker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 118, 253–261 (1995).
10.
Qiu K, Qiang H, Xigian C, Hui L, Shuwen D, Wei L. Pregnancy-related immune changes and demyelinating diseases of the central nervous system. Front. Neurol. 10, 1070 (2019).
11.
Finkelstejn A, Brooks JB, Paschoal FM Jr, Fragoso YD. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG 118, 790–797 (2011).
12.
Ghezzi A, Caputo D. Pregnancy: a factor influencing the course of multiple sclerosis? Eur. Neurol. 20, 115–117 (1981).
13.
Korn-Lubetzki I, Kahama E, Cooper G, Oded A. Activity of multiple sclerosis during pregnacy and puerperium. Ann. Neurol. 16, 229–231 (1984).
14.
Frith JA, McLeod JG. Pregnancy and multiple sclerosis. J. Neurol. Neurosurg. Psych. 51, 495–498 (1988).
15.
Bernardi S, Grasso MG, Bertollini R, Orzi F, Fieschi C. The influence of pregnancy on relapses in multiple sclerosis: a cohort study. Acta Neurol. Scand. 84, 403–406 (1991).
16.
Nelson LM, Franklin GM, Jones MC. Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. JAMA 259, 3441–3443 (1988).
17.
Roullet E, Verdier-Taillefer MH, Amarenco P, Gharbi G, Alperovitch A, Marteau R. Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients. J. Neurol. Neurosurg. Psych. 56, 1062–1065 (1993).
18.
Sadovnick AD, Eisen K, Hashimoto SA et al. Pregnancy and multiple sclerosis. A prospective study. Arch. Neurol. 51, 1120–1124 (1994).
19.
Confavreux C, Hutchinson M, Hours MM, Cortinovis P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group. N. Engl. J. Med. 339, 285–291 (1998).
20.
Salemi G, Callari G, Gammino M et al. The relapse rate of multiple sclerosis changes during pregnancy: a cohort study. Acta Neurol. Scand. 110, 23–26 (2004).
21.
Airas L, Jalkanen A, Alanen A, Pirttila T, Marttila RJ. Breastfeeding, postpartum and pregnancy disease activity in multiple sclerosis. Neurology 75, 474–476 (2010).
22.
Portaccio E, Ghezzi A, Hakki B et al. Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurology 77, 145–150 (2011).
23.
Keyhanian K, Davoudi V, Etemandifar M, Amin M. Better prognosis of multiple sclerosis in patients who experienced a full-term pregnancy. Eur. Neurol. 68, 150–155 (2012).
24.
Hughes SE, Spelman T, Gray OM et al. Predictors and dynamics of postpartum relapses in women with multiple sclerosis. Mult. Scler. 20, 739–746 (2014).
25.
Karp I, Manganas A, Sylvestre MP, Ho A, Roger E, Duquette P. Does pregnancy alter the long-term course of multiple sclerosis?. Ann. Epidemiol. 24, 504e2–508e2 (2014).
26.
Fares J, Nassar AH, Gebeily S, Kobeissy F, Fares Y. Pregnancy outcomes in Lebanese women with multiple sclerosis (the LeMS study): a prospective multicentre study. BMJ Open 6, e011210 (2016).
27.
Benoit A, Durand-Dubief F, Amato MP et al. History of multiple sclerosis in 2 successive pregnancies: a French and Italian cohort. Neurology 87, 1360–1367 (2016).
28.
Cuello JP, Martinez Ginés ML, Martin Barriga ML, de Andrés C. Multiple sclerosis and pregnancy: a single-centre prospective comparative study. Neurologia 32, 92–98 (2017).
29.
Jesus-Ribeiro J, Correia I, Martins AI et al. Pregnancy in multiple sclerosis: a Portuguese cohort study. Mult. Scler. Relat. Disord. 17, 63–68 (2017).
30.
Lai W, Kinoshita M, Peng A et al. Does pregnancy affect women with multiple sclerosis? A prospective study in Western China. J. Neuroimmunol. 321, 24–28 (2018).
31.
Houtchens MK, Edwards NC, Phillips AL. Relapses and disease-modifying drug treatment and live birth in US women with MS. Neurology 91, e1570–e1578 (2018).
32.
Bsteh G, Algrang L, Hegen H et al. Pregnancy and multiple sclerosis in the DMT era: a cohort study in Western Austria. Mult. Scler. J. 26, 79–68 (2020).
33.
Alroughani R, Akhtar S, Zeineddine M et al. Risk of relapses during pregnancy among multiple sclerosis patients. Mult. Scler. Relat. Disord. 34, 9–13 (2019).
34.
MacDonald SC, McElrath TF, Hernandez-Diaz S. Pregnancy outcomes in women with multiple sclerosis. Am. J. Epidemiol. 188, 57–66 (2019).
35.
Verdru P, Theys P, D'Hooghe MB, Carton H. Pregnancy and multiple sclerosis: the influence of long term disability. Clin. Neurol. Neurosurg. 96, 38–41 (1994).
36.
Vukusic S, Confavreux C. Pregnancy and multiple sclerosis: the children of PRIMS. Clin. Neurol. Neurosurg. 108, 266–279 (2006).
37.
Poser S, Poser W. Multiple sclerosis and gestation. Neurology 33, 1422–1427 (1983).
38.
Thompson DS, Nelson LM, Burns A, Burks JS, Franklin GM. The effects of pregnancy in multiple sclerosis: a retrospective study. Neurology 36, 1097–1099 (1986).
39.
Weinshenker BG, Hader W, Carriere W, Baskerville J, Ebers GC. The influence of pregnancy on disability from multiple sclerosis: a population-based study in Middlesex County, Ontario. Neurology 39, 1438–1440 (1989).
40.
Koch M, Uyttenboogaart M, Heersema D, Steen C, De Keyser J. Parity and secondary progression in multiple sclerosis. J. Neurol. Neurosurg. Psych. 80, 676–678 (2009).
41.
Ramagopalan S, Yee I, Byrnes J, Guimond C, Ebers G, Sadovnick D. Term pregnancies and the clinical characteristics of multiple sclerosis. A population based study. J. Neurol. Neurosurg. Psych. 83, 793–795 (2012).
42.
D'Hooghe MB, Haentjens J, Nagels G, D'Hooghe T, De Keyser J. Menarche, oral contraceptives, pregnancy, and progression of disability in relapsing onset and progressive onset multiple sclerosis. J. Neurol. 259, 855–861 (2012).
43.
Masera S, Cavalla P, Prosperini L et al. Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis. Mult. Scler. J. 21, 1291–1297 (2015).
44.
Altintas A, Najar B, Gozubatik-Cellic G, Menku SF. Pregnancy data in a Turkish multiple sclerosis population. Eur. Neurol. 74, 296–302 (2015).
45.
D'Amico E, Leone C, Patti F. Offspring number does not influence reaching the disability milestones in multiple sclerosis: a seven-year follow-up study. Int. J. Mol. Sci. 17, 234 (2016).
46.
Dahl J, Myhr K, Dalveit AK, Hoff JM, Gilhus NE. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology 65, 1961–1963 (2005).
47.
Chen YH, Lin HL, Lin HC. Does multiple sclerosis increase risk of adverse pregnancy outcomes: a population-based study. Mult. Scler. J. 15, 606–612 (2009).
48.
Hanulikova P, Vlk R, Meluzinova E et al. Pregnancy and multiple sclerosis-outcomes analysis. Ceska Gynekol. 78, 142–148 (2013).
49.
Goldacre A, Pakpoor J, Goldacre M. Perinatal characteristics and obstetric complications in mothers with multiple sclerosis. Mult. Scler. Relat. Disord. 12, 4–8 (2017).
50.
Houtchens MK, Edwards NC, Schneider G, Stern K, Phillips AL. Pregnancy rates and outcomes in women with and without MS in the United States. Neurology 91, e1559–e1569 (2018).
51.
Fong A, Chau CT, Quant C, Duffy J, Pan D, Ogunyemi DA. Multiple sclerosis in pregnancy: prevalence, sociodemographic features, and obstetrical outcomes. J. Matern. Fetal Neonatal Med. 31, 382–387 (2018).
52.
Mueller BA, Zhang J, Critchlow C. Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis. Am. J. Obstetr. Gynecol. 186, 446–452 (2002).
53.
van der Kop ML, Pearce MS, Dahlgren L et al. Neonatal and delivery outcomes in women with multiple sclerosis. Ann. Neurol. 70, 41–50 (2011).
54.
Kelly VM, Nelson LM, Chakravarty E. Obstetric outcomes in women with multiple sclerosis and epilepsy. Neurology 73, 1831–1836 (2009).
55.
Balslev Andersen J, Iskov Kopp T, Sellebjerg F, Magyari. Pregnancy related and perinatal outcomes among Danish women with multiple sclerosis. A nationwide population-based registry study. Mult. Scler. J. 25, 619–620, Abstract 1081 (2019).
56.
Worthington J, Jones R, Crawford M, Forti A. Pregnancy and multiple sclerosis – a 3-year prospective study. J. Neurol. 241, 228–233 (1994).
57.
Jalkanen A, Alanen A, Airas L. Finnish multiple sclerosis and pregnancy study group. Mult. Scler. 16, 950–955 (2020).
58.
Flachenecker P, Hartung HP. Multiple sclerosis and pregnancy: overview and status of the European multicenter PRIMS study. Nervenarzt 66, 87–104 (1995).
59.
Lavie C, Rollot F, Durand-Dubief F et al. Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS. Mult. Scler. J. 25, 591–600 (2019).
60.
Laplaud DA, Leray E, Barriere P, Wiertlewski S, Moreau T. Increase in multiple sclerosis relapse rate following in vitro fertilization. Neurology 66, 1280–1281 (2006).
61.
Hellwig K, Beste C, Brune N et al. Increased MS relapse rate during assisted reproduction technique. J. Neurol. 255, 592–593 (2008).
62.
Michael L, Foucher Y, Vukusic S et al. Increased risk of multiple sclerosis relapse after in vitro fertilisation. J. Neurol. Neurosurg. Psych. 83, 796–802 (2012).
63.
Correale J, Farez MF, Ysrraelit MC. Increase in multiple sclerosis activity after assisted reproduction technology. Ann. Neurol. 72, 682–694 (2012).
64.
Bove R, Rankin K, Zhao C et al. Effect of assisted reproductive technology on multiple sclerosis relapses: case series and meta-analysis. Mult. Scler. J. 26, 1410–1419 (2010).
65.
Moberg JY, Laursen B, Thygesen LC, Magyari M. Reproductive history of the Danish multiple sclerosis population: a register-based study. Mult. Scler. J. 26, 902–911 (2020).
66.
Berenguer-Ruiz L, Gimenez-Martinez J, PalazonBru A, Sempere AP. Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy. J. Neurol. 266, 2512–2517 (2019).
67.
Portaccio E, Ghezzi A, Hakiki B et al. Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease-modifying drugs. J. Neurol. Neurosurg. 85, 845–850 (2014).
68.
Popova EV, Korobko DS, Bulatova EV et al. A retrospective analysis of the effect of pregnancy on the course of multiple sclerosis. Zh. Nevrol. Psikhiatr. Im. SS Korsakova 115, 18–21 (2015).
69.
Airas L. Hormonal and gender-related Immune changes in multiple sclerosis. Acta Neurol. Scand. 132, 62–70 (2015).
70.
Krysko KM, Rutatangwa A, Graves J, Lazar A, Waubant E. Association between breastfeeding and postpartum multiple sclerosis relapses: a systematic review and meta-analysis. JAMA Neurol. 77, 327–338 (2020).
71.
Portaccio E, Amato MP. Breastfeeding and postpartum relapses in multiple sclerosis patients. Mult. Scler. J. 25, 1211–1216 (2019).
72.
Langer-Gould A, Smith JB, Albers KB et al. Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort. Neurology 94, e1939–e1949 (2020).
73.
Xie Y, Tian Z, Han F, Liang S, Gao Y, Wu D. Factors associated with relapses in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis. Medicine (Baltimore) 99, e20885 (2020).
Information & Authors
Information
Published In
Pages: 175 - 186
PubMed: 33565886
Copyright
© 2021 Future Medicine Ltd.
History
Received: 22 September 2020
Accepted: 30 November 2020
Published online: 10 February 2021
Keywords:
Topics
Authors
Metrics & Citations
Metrics
Article Usage
Article usage data only available from February 2023. Historical article usage data, showing the number of article downloads, is available upon request.
Citations
How to Cite
The effects of pregnancy on relapse rates, disability and peripartum outcomes in women with multiple sclerosis: a systematic review and meta-analysis. (2021) Journal of Comparative Effectiveness Research. DOI: 10.2217/cer-2020-0211
Export citation
Select the citation format you wish to export for this article or chapter.
Citing Literature
- Lorena Viviana López Reyes, Miguel Ángel Robles Sanchez, Montserrat Aroca Alsina, Mireia Resina Sallés, Laura Fonseca, Patricia Arrieta Perna, Cristina Calderer Suárez, Samuel Sánchez Pous, Gaizka Loyola Sanmillan, Paula Tagliani, Xavier Montalban, Mar Tintoré, Luciana Midaglia, How misinformation affects family planning choices for women with multiple sclerosis, Patient Education and Counseling, 10.1016/j.pec.2026.109632, 149, (109632), (2026).
- Ewa Krzystanek, Paweł Gęszka, Mateusz Gawin, Magdalena Fabian, Aleksandra Foryś, Anetta Lasek-Bal, The Knowledge About the Impact of Multiple Sclerosis on Pregnancy and Maternity Among Patients with Multiple Sclerosis, Journal of Clinical Medicine, 10.3390/jcm15124625, 15, 12, (4625), (2026).
- Zi-Jun Ma, Jun Chen, Chen-Xi Yang, Shun-Ping Lin, Quan Gong, Zachary Braunstein, Ying-Ying Wei, Xiao-Quan Rao, Ji-Xin Zhong, Immune microenvironment dynamics in pregnant patients with concomitant autoimmune diseases: mechanisms, challenges, and clinical significance, Military Medical Research, 10.1016/j.mmr.2026.100015, 13, 1, (100015), (2026).
- Virginie Trabaud, Appoline Zimmerman, Audrey Gnisci, Bertrand Audoin, Blandine Courbiere, Multiple sclerosis, fertility, pregnancy, and assisted reproductive technology: Current knowledge, Journal of Gynecology Obstetrics and Human Reproduction, 10.1016/j.jogoh.2025.103061, 55, 1, (103061), (2026).
- Sara Terrim, Samira Luisa Apostolos-Pereira, Thiago Ivan Vilchez Santillan, Tarso Adoni, Dagoberto Callegaro, Guilherme Diogo Silva, Risk Factors for Relapses in Multiple Sclerosis Beyond Disease-Modifying Therapy: An Umbrella Review of Systematic Reviews and Meta-Analyses, Sclerosis, 10.3390/sclerosis3040041, 3, 4, (41), (2025).
- Diego F. Wyszynski, Pregnancy and Multiple Sclerosis: A Narrative Review of Clinical Outcomes, Disease Activity, and Treatment Considerations, Multiple Sclerosis and Related Disorders, 10.1016/j.msard.2025.106643, 102, (106643), (2025).
- Manuela Andreea Ciapă, Vlad Constantin Donica, Claudia Florida Costea, Anisia Iuliana Alexa, Alexandra Lori Donica, Camelia Margareta Bogdănici, The Relationship Between OCT and VEP Parameters with Disability and Disease Duration in Relapsing–Remitting Multiple Sclerosis, Diagnostics, 10.3390/diagnostics15172181, 15, 17, (2181), (2025).
- Claire Z. Kalpakjian, Lukonde Mulenga, Shannen M. McIntosh, Jodi M. Kreschmer, Rebecca Parten, Heidi Haapala, Elizabeth S. Langen, Sara A. S. Rosenblum, Svati Pazhyanur, Susan Carlson, Maryam Berri, Susan D. Ernst, Pregnancy and physical disability: A scoping review, Women's Health, 10.1177/17455057251338424, 21, (2025).
- Salsabil Zubedi, Hana Al-Ali, Nadia Rabeh, Sara Aljoudi, Zakia Dimassi, Hamdan Hamdan, Life Chapters: Navigating Multiple Sclerosis Across Pregnancy, Breastfeeding, Epidemiology, and Beyond, Exploring the Effects of Diet on the Development and Prognosis of Multiple Sclerosis (MS), 10.1007/978-981-97-4673-6_2, (17-44), (2024).
- Shoboo Rahmati, Zahra Galavi, Batoul Kavyani, Homa Arshadi, Jaason Geerts, Hamid Sharifi, Maternal and neonatal outcomes in pregnant women with multiple sclerosis disease: A systematic review and meta-analysis, Midwifery, 10.1016/j.midw.2024.104004, 134, (104004), (2024).
- See more